Tower Research Capital (TRC)’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Tower Research Capital (TRC)’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,348	Closed	-$80K	–	6645
2021 Q2	$80K	Sell	2,348 -1,218	-34%	-$31K	﹤0.01%	2608
2021 Q1	$83K	Sell	3,566 -1,893	-35%	-$57.3K	﹤0.01%	2735
2020 Q4	$157K	Buy	5,459 +2,916	+115%	+$73.4K	﹤0.01%	1935
2020 Q3	$52K	Sell	2,543 -3,553	-58%	-$86.7K	﹤0.01%	3527
2020 Q2	$183K	Buy	6,096 +5,996	+5,996%	+$216K	0.01%	1868
2020 Q1	$3K	Buy	+100	New	+$3.48K	﹤0.01%	2527
2019 Q3	–	Sell	-166	Closed	-$2K	–	4731
2019 Q2	$2K	Sell	166 -819	-83%	-$9.12K	﹤0.01%	3363
2019 Q1	$13K	Buy	985 +922	+1,463%	+$8.26K	﹤0.01%	2551
2018 Q4	$0	Sell	63 -1,027	-94%	-$6.19K	﹤0.01%	4591
2018 Q3	$7K	Buy	+1,090	New	+$10.4K	﹤0.01%	2993

Tower Research Capital (TRC)'s CNST Position: Q3 2021 in Review

Tower Research Capital (TRC) sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 2,348 shares — an estimated $80K sold.

Tower Research Capital (TRC) first reported a position in CNST in Q3 2018 and held it in 10 quarters. The position peaked at $183K in Q2 2020. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Tower Research Capital (TRC) reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Tower Research Capital (TRC) sold 2,348 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $80K.
Tower Research Capital (TRC) first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2018 and held it in 10 quarters.
Tower Research Capital (TRC)'s Constellation Pharmaceuticals, Inc. position peaked at $183K in Q2 2020.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.